Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 3 von 813
BMJ, 2012-01, Vol.344 (jan03 1), p.d7292-d7292
International edition, 2012
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis
Ist Teil von
  • BMJ, 2012-01, Vol.344 (jan03 1), p.d7292-d7292
Auflage
International edition
Ort / Verlag
England: BMJ Publishing Group
Erscheinungsjahr
2012
Quelle
Applied Social Sciences Index & Abstracts (ASSIA)
Beschreibungen/Notizen
  • To review patterns of publication of clinical trials funded by US National Institutes of Health (NIH) in peer reviewed biomedical journals indexed by Medline. Cross sectional analysis. Clinical trials funded by NIH and registered within ClinicalTrials.gov (clinicaltrials.gov), a trial registry and results database maintained by the US National Library of Medicine, after 30 September 2005 and updated as having been completed by 31 December 2008, allowing at least 30 months for publication after completion of the trial. Publication and time to publication in the biomedical literature, as determined through Medline searches, the last of which was performed in June 2011. Among 635 clinical trials completed by 31 December 2008, 294 (46%) were published in a peer reviewed biomedical journal, indexed by Medline, within 30 months of trial completion. The median period of follow-up after trial completion was 51 months (25th-75th centiles 40-68 months), and 432 (68%) were published overall. Among published trials, the median time to publication was 23 months (14-36 months). Trials completed in either 2007 or 2008 were more likely to be published within 30 months of study completion compared with trials completed before 2007 (54% (196/366) v 36% (98/269); P<0.001). Despite recent improvement in timely publication, fewer than half of trials funded by NIH are published in a peer reviewed biomedical journal indexed by Medline within 30 months of trial completion. Moreover, after a median of 51 months after trial completion, a third of trials remained unpublished.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX